Atlas Trials

Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis

Clinical trial NCT01895439 · COMPLETED

Trial details

NCT number
NCT01895439
Sponsor
University of Jordan
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2012-10-01
Primary completion
2016-02-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.